Cardiff Oncology Inc.

01/26/2021 | Press release | Distributed by Public on 01/26/2021 07:05

Cardiff Oncology Receives 'Study May Proceed' from FDA to Initiate Phase 2 Trial of Onvansertib in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)